HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -76.2% | 426 | -62.0% | 0.00% | -20.0% |
| Q1 2022 | $21,000 | -43.2% | 1,121 | +6.7% | 0.01% | -37.5% |
| Q4 2021 | $37,000 | 0.0% | 1,051 | +3.3% | 0.01% | 0.0% |
| Q3 2021 | $37,000 | +8.8% | 1,017 | +19.1% | 0.01% | 0.0% |
| Q2 2021 | $34,000 | +61.9% | 854 | +15.7% | 0.01% | +60.0% |
| Q1 2021 | $21,000 | -12.5% | 738 | -1.3% | 0.01% | +25.0% |
| Q4 2020 | $24,000 | 0.0% | 748 | -0.7% | 0.00% | -20.0% |
| Q3 2020 | $24,000 | +26.3% | 753 | +7.4% | 0.01% | +25.0% |
| Q2 2020 | $19,000 | +46.2% | 701 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $13,000 | 0.0% | 701 | +30.3% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | 0.0% | 538 | -22.9% | 0.00% | +50.0% |
| Q3 2019 | $13,000 | -40.9% | 698 | -2.5% | 0.00% | -50.0% |
| Q1 2019 | $22,000 | +37.5% | 716 | +5.1% | 0.00% | +33.3% |
| Q4 2018 | $16,000 | – | 681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |